Audio
Commentary and Podcast on Landmark Gene Therapy Clinical Trial for Hemophilia B | PRLog
Commentary and Podcast on Landmark Gene Therapy Clinical Trial for Hemophilia B. A recent article in the New England Journal of Medicine showed that Factor IX gene therapy in patients with hemophilia B was able to convert severe hemophilia to moderate or even mild disease - PR11747790
Results 1-1 of 1
Page:

